Nova Eye Medical (ASX:EYE) has completed the first surgeries with iTrack Advance and reported first sales in the US after receiving clearance from the US FDA.

Surgeons experienced with iTrack will continue to be introduced to iTrack Advance for the treatment of glaucoma.

The company aims to accelerate sales as new customer interest is generated.